Combined PD-1, BRAF and MEK inhibition in advanced BRAF-mutant melanoma: safety run-in and biomarker cohorts of COMBI-i - Concepedia

Concepedia

Publication | Closed Access

Combined PD-1, BRAF and MEK inhibition in advanced BRAF-mutant melanoma: safety run-in and biomarker cohorts of COMBI-i

121

Citations

47

References

2020

Year

Reinhard Dummer, Célèste Lebbé, Victoria Atkinson, Mario Mandalà, Paul Nathan, Ana Arance, Erika Richtig, Naoya Yamazaki, Caroline Robert, Dirk Schadendorf,

Nature Medicine

OncologyMedicineMelanomaImmunologyImmune Checkpoint InhibitorAdvanced Braf-mutant MelanomaMek InhibitionSafety Run-inCancer BiologyRadiation OncologyTumor BiologySkin Cancer

References

	Year	Citations

Page 1

Page 1